Search

Hutchison China MediTech Ltd ADR

Open

SectorHealthcare

10.45 -5.86

Overview

Share price change

24h

Current

Min

10.45

Max

11.12

Key metrics

By Trading Economics

Income

978K

Sales

135M

P/E

Sector Avg

4.272

62.58

Profit margin

0.722

Employees

1,796

EBITDA

-14M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+37.59% upside

Market Stats

By TradingEconomics

Market Cap

1.9B

Previous open

16.31

Previous close

10.45

News Sentiment

By Acuity

100%

0%

322 / 340 Ranking in Healthcare

Hutchison China MediTech Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 lip 2026, 23:56 UTC

Correlated Moves
News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

22 lip 2026, 23:56 UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

22 lip 2026, 23:51 UTC

News

Rollins Inc shares fell after second-quarter results missed expectations. Adjusted EPS was $0.32, below the consensus estimate of $0.34, amid slowing growth.

22 lip 2026, 23:51 UTC

Social Media
News

CSX Corp reported second-quarter revenue of $3.94 billion and EPS of $0.54, exceeding expectations, leading to higher shares in after-market trading.

22 lip 2026, 23:51 UTC

Social Media
News

Joby Aviation will release its Q2 2026 results on August 5, generating positive investor sentiment. Shares are trading higher in after-market hours.

22 lip 2026, 23:51 UTC

Social Media
News

Southwest Airlines reported second-quarter earnings above estimates but missed on revenue, leading to shares trading lower in after-market hours.

22 lip 2026, 23:51 UTC

News

Norfolk Southern Corp shares are trading lower in after-market hours following Union Pacific and Canadian National Railway's agreement that may impact its competitive position.

22 lip 2026, 23:51 UTC

ETF Constituents
Social Media
News

Invesco QQQ Trust Series I is lower in after-market hours amid concerns over rising crude oil prices and geopolitical tensions affecting market sentiment.

22 lip 2026, 23:51 UTC

Social Media
Correlated Moves
News

Amazon.com Inc is under Senate investigation for alleged Chinese influence on its marketplace, contributing to a decline in investor sentiment and stock price after hours.

22 lip 2026, 23:51 UTC

ETF Constituents
News
Macro News

Vanguard Information Technology ETF is higher in after-market hours, driven by positive sentiment ahead of earnings from major tech firms and strong performances from key holdings.

22 lip 2026, 23:46 UTC

News

EQT Corporation's stock rose after it raised full-year natural gas production guidance and secured long-term supply agreements, despite lower-than-expected earnings.

22 lip 2026, 23:46 UTC

Social Media
News

Intel explores a partnership with SK Hynix for its Ohio facility. Shares are trading higher after securing Fortinet as its first external foundry customer.

22 lip 2026, 23:46 UTC

Social Media
News

Crown Castle reported second-quarter adjusted FFO of $1.13, exceeding estimates. Shares are higher in after-market trading following the results and strategic business sale.

22 lip 2026, 23:41 UTC

News

Goosehead Insurance shares rise in after-market hours following strong Q2 results, with revenue of $113.4 million and a leadership transition announcement.

22 lip 2026, 23:41 UTC

News

Community Health Systems reported a significant decline in net income and lowered its full-year EPS guidance, leading shares to trade lower in after-market hours.

22 lip 2026, 23:41 UTC

Social Media
News

Kinder Morgan's Q2 earnings of $0.37 per share exceeded estimates, driving shares higher in after-market trading. Revenue rose to $4.48 billion, surpassing expectations.

22 lip 2026, 23:36 UTC

Social Media
Correlated Moves
News

Shutterstock shares are lower in after-market hours following the suspension of dividends and the resignation of Chief Accounting Officer Steven Ciardiello.

22 lip 2026, 23:36 UTC

Correlated Moves
News

Microsoft shares are lower in after-market hours amid a securities class action lawsuit regarding its Copilot products and concerns over capital expenditures ahead of earnings.

22 lip 2026, 23:36 UTC

Social Media
News

Rocket Lab shares are lower in after-market hours, reflecting broader sector trends. The company will release second-quarter 2026 results on August 10, 2026.

22 lip 2026, 23:31 UTC

Social Media
News

Leslie's Inc shares declined in after-hours trading amid reports of a potential Chapter 11 bankruptcy, raising concerns about the company's financial stability.

22 lip 2026, 23:26 UTC

News

Synopsys Inc will report third-quarter results on August 26, 2026, after market close. Shares are trading higher in after-market hours.

22 lip 2026, 23:22 UTC

Social Media
News

Tesla Inc. shares declined in after-hours trading following a Q2 earnings miss, with adjusted EPS at $0.33 against expectations of $0.51.

22 lip 2026, 23:22 UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

22 lip 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

22 lip 2026, 23:16 UTC

News

Interactive Brokers reported second-quarter net revenue growth of 28% to $1.90 billion, driven by a 67% increase in customer margin loans.

22 lip 2026, 23:11 UTC

Social Media
News

Lockheed Martin announced a quarterly dividend of $3.45 per share, boosting investor sentiment. Shares are higher in after-market trading following the announcement.

22 lip 2026, 23:06 UTC

News

Constellation Energy Corp shares are lower in after-market trading, influenced by geopolitical tensions and concerns over potential oil supply disruptions.

22 lip 2026, 23:06 UTC

News

Dollar Tree shares are lower in after-market trading amid scrutiny over new price scanners and rising costs, prompting concerns about customer loyalty.

22 lip 2026, 23:06 UTC

News

General Motors raised its 2026 profit outlook to $14 billion to $16 billion, boosting shares higher in after-market hours following strong EBIT performance.

22 lip 2026, 23:02 UTC

Social Media
News

QuantumScape Corp's shares declined in after-market hours following a narrower loss and lowered capital expenditures guidance amid concerns over future cash flow.

Peer Comparison

Price change

Hutchison China MediTech Ltd ADR Forecast

Price Target

By TipRanks

37.59% upside

12 Months Forecast

Average 15.3 USD  37.59%

High 17 USD

Low 13.6 USD

Based on 2 Wall Street analysts offering 12 month price targets forHutchison China MediTech Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat